Most lately, it's been discovered that conolidine and the above derivatives act over the atypical chemokine receptor 3 (ACKR3. Expressed in very similar locations as classical opioid receptors, it binds to your big range of endogenous opioids. As opposed to most opioid receptors, this receptor acts as a scavenger https://juliak384ari0.blogunteer.com/profile